<https://rdf.molmedb.upol.cz/reference/ref1687> <http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane46>,
		<https://rdf.molmedb.upol.cz/interaction/method33>,
		<https://identifiers.org/molmedb/MM21738>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2009.06.096"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method71>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/ontology/bibo/pmid> "19616432"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/bibliographicCitation> "Fish PV, Wakenhut F, Ryckmans T, Stobie A.: Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template. Bioorg Med Chem Lett, Volume 19 (16), 2009"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane21>,
		<https://identifiers.org/molmedb/MM21738.1> .
<https://rdf.molmedb.upol.cz/interaction/int977821> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1687> .
<https://rdf.molmedb.upol.cz/interaction/int974731> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1687> .
<https://rdf.molmedb.upol.cz/interaction/int974584> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1687> .
<https://rdf.molmedb.upol.cz/interaction/int977453> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1687> .